Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Pulmonary AND Bronchogenic carcinoma)
49,655 results
  • Postoperative radiotherapy for non-small cell lung cancer. [Review]
  • CDCochrane Database Syst Rev 2016 Oct 11; 10:CD002142
  • Burdett S, Rydzewska L, … PORT Meta‐analysis Trialists Group
  • CONCLUSIONS: Results from 11 trials and 2343 participants show that PORT is detrimental to those with completely resected non-small cell lung cancer and should not be used in the routine treatment of such patients. Results of ongoing RCTs will clarify the effects of modern radiotherapy in patients with N2 tumours.
New Search Next